[3-(1,3-DIHYDRO-1,3-DIOXO-2H-ISOINDOLE-2-YL)-2,6-DIOXO-PIPERIDINE-1-YL]-ACETIC-ACID-TERT.-BUTYLESTER
Compound with spectra: 1 NMR
![[3-(1,3-DIHYDRO-1,3-DIOXO-2H-ISOINDOLE-2-YL)-2,6-DIOXO-PIPERIDINE-1-YL]-ACETIC-ACID-TERT.-BUTYLESTER](/api/compound/Lpgru8xXJgC.png?ph=true&h=300&w=458 "[3-(1,3-DIHYDRO-1,3-DIOXO-2H-ISOINDOLE-2-YL)-2,6-DIOXO-PIPERIDINE-1-YL]-ACETIC-ACID-TERT.-BUTYLESTER")
| SpectraBase Compound ID | Lpgru8xXJgC |
|---|---|
| InChI | InChI=1S/C19H20N2O6/c1-19(2,3)27-15(23)10-20-14(22)9-8-13(18(20)26)21-16(24)11-6-4-5-7-12(11)17(21)25/h4-7,13H,8-10H2,1-3H3 |
| InChIKey | XCQJVUBHBZQKCI-UHFFFAOYSA-N |
| Mol Weight | 372.38 g/mol |
| Molecular Formula | C19H20N2O6 |
| Exact Mass | 372.132136 g/mol |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | DMSO-D6 |
2-(2,6-diketo-3-phthalimido-piperidino)acetic acid methyl ester
2-AMINO-ACETIC-ACID-[3-(1,3-DIHYDRO-1,3-DIOXO-2H-ISOINDOLE-2-YL)-2,6-DIOXO-PIPERIDINE-1-YL-METHYL]-ESTER-HCL
SUCCINIC-ACID-MONO-[3-(1,3-DIHYDRO-1,3-DIOXO-2H-ISOINDOLE-2-YL)-2,6-DIOXO-PIPERIDINE-1-YL-METHYL]-ESTER
N-TERT.-BUTYLOXYCARBONYL-2-AMINO-ACETIC-ACID-[3-(1,3-DIHYDRO-1,3-DIOXO-2H-ISOINDOLE-2-YL)-2,6-DIOXO-PIPERIDINE-1-YL-METHYL]-ESTER
2-AMINO-3-METHYL-BUTYRIC-ACID-[3-(1,3-DIHYDRO-1,3-DIOXO-2H-ISOINDOLE-2-YL)-2,6-DIOXO-PIPERIDINE-1-YL-METHYL]-ESTER-HCL
(.alpha.R,3R)N-(2-Hydroxy-1-phenylethyl)-3-phthalimidopiperidin-2-one
(S/R)-2-Phthaloylamidopent-4-enoic acid [(2S)-methoxycarbonylpyrrolidinyl]amide
4-Phenylthiocarbonyl-2-(N-phthaloyl)-N-[1-(tert-butoxycarbonyl)-2-tert-butyloxyethyl]butanamide
1,3-dioxo-alpha-{2-[(6-ethoxy-2-benzothiazolyl)carbamoyl]ethyl}-2-isoindolineacetic acid
2-{[2-(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)-3-phenylpropanoyl]amino}benzoic acid
| Title | Journal or Book | Year |
|---|---|---|
| Synthesis and immunological activity of water-soluble Thalidomide prodrugs | Bioorganic & Medicinal Chemistry | 2001 |